Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2025-04-29 Regulatory Filings
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - LGP 4 pages 14.8KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of conditional rights to securities for LITTLE GREEN PHARMA LTD. It provides specific information about securities that have ceased, including the number, type, and reason for cessation. The document is an announcement about changes in the company's issued capital related to securities ceasing to exist. It does not contain financial statements, management discussion, or detailed financial data. The document length is 4020 characters, which is relatively short and focused on a specific event. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about securities cessation and does not fit other more specific categories like capital changes (SHA) which typically involve new issues or stock splits rather than cessation/lapse of rights. Therefore, the best classification is Regulatory Filings (RNS).
2025-04-29 English
Quarterly Activities Report and Appendix 4C 18 pages 6.8MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report and Appendix 4C' and contains detailed financial and operational data for the quarter ending 31 March 2025. It includes revenue figures, cash receipts, segment and product category breakdowns, cash flow information, and updates on acquisitions and market conditions. The presence of substantive financial data and analysis for a period shorter than a full fiscal year, along with the quarterly focus, aligns with the definition of an Interim / Quarterly Report (IR). The document is not merely an announcement or a brief summary but a comprehensive quarterly report with financial and operational details. Q3 2025
2025-04-29 English
QUEST Initiative 12-month results 6 pages 562.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated April 4, 2025, from Little Green Pharma Ltd. It details the results of a 12-month clinical study (QUEST Initiative) on medicinal cannabis and its effects on chronic conditions. The content focuses on study findings, patient outcomes, and future research plans. There are no financial statements, regulatory certifications, or management discussions typical of annual or interim reports. The document is a detailed announcement of research results and company updates rather than a formal financial or regulatory filing. It is not a report publication announcement since it contains substantive content and analysis rather than just a notice of report availability. The document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about clinical study results and company activities that do not fit other specific categories like earnings release or management report.
2025-04-03 English
French medicinal cannabis legislation defined 3 pages 710.7KB
Regulatory Filings Classification · 90% confidence The document is an ASX announcement with a length of 15,000 characters, containing numerous omitted pictures and no visible textual content to analyze. There is no explicit mention of financial results, management changes, voting results, or other specific report types. The document appears to be a general announcement or regulatory filing rather than a full report or detailed presentation. Given the lack of substantive text and the nature of ASX announcements, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories.
2025-04-01 English
Application for quotation of securities - LGP 8 pages 24.5KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used for the application for quotation of securities. It details the issuance and conversion of options and convertible securities into ordinary shares, including specifics about the number of securities, issue dates, and whether they rank equally with existing securities. The document is focused on the issuance and quotation of new shares resulting from exercised options or converted securities, which is a capital change event. It is not a financial report, earnings release, or management discussion, nor is it a regulatory filing about legal or governance matters. The document is not announcing a report publication but is itself an official announcement of a capital market transaction. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length (over 10,000 characters) and detailed content confirm it is not a mere announcement of a report but the actual application for quotation of securities.
2025-03-19 English
Initial Directors Interest Notice x 2 4 pages 205.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the securities interests of newly appointed directors, including direct and indirect holdings, and notes the date of appointment. This type of document is a formal notification of personal share transactions or holdings by company directors. It does not contain financial performance data, management discussion, or other report content. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is not a brief announcement or a report publication notice but a detailed insider transaction report.
2025-03-03 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.